Skip to main content
. 2012 Jan 17;27(2):494–497. doi: 10.1093/ndt/gfr638

Fig. 2.

Fig. 2.

(A) Endostatin, (B) PEDF and (C) KLF-2 urine concentrations, normalized using (urinary creatinine), in CAD patients (1–3), in biopsy-confirmed and non-biopsy confirmed CAD-0 and in healthy non-transplant controls.